SCHEMBL21360741

SCHEMBL21360741

CCC1C(=O)CCc2c(F)cc(OC)cc21

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 1/20 0.36
HTR2C P28335 3/20 0.34
HTR2B P41595 3/20 0.34
HTR2A P28223 2/20 0.34
ADRB2 P07550 1/20 0.32
HTR1A P08908 1/20 0.32
ADRA2A P08913 1/20 0.32
ADRA2B P18089 1/20 0.32
SLC6A2 P23975 1/20 0.32
HRH1 P35367 1/20 0.32
OPRM1 P35372 1/20 0.32
OPRK1 P41145 1/20 0.32
HTR5A P47898 1/20 0.32
SLC6A3 Q01959 1/20 0.32
SIGMAR1 Q99720 1/20 0.32
FPR2 P25090 4/20 0.32
HCRTR1 O43613 1/20 0.32
HCRTR2 O43614 1/20 0.32
GRK6 P43250 1/20 0.32
MAOB P27338 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21360773 0.90 TAAR1 (0.33) TAAR1HTR2CHTR2BHTR2AFPR2
SCHEMBL21360778 0.86 HTR2B (0.33) TAAR1HTR2CHTR2BHTR2AHTR1A
SCHEMBL21360807 0.82 TAAR1 (0.34) TAAR1HTR2CHTR2BHTR2AFPR2
SCHEMBL11705648 0.73 HTR2C (0.51) HTR2CHTR2BHTR2AADRB2HTR1A
SCHEMBL3897835 0.70 HTR2A (0.47) HTR2CHTR2BHTR2AADRB2HTR1A
SCHEMBL21360725 0.67 HTR2A (0.39) HTR2CHTR2BHTR2AGAA
SCHEMBL3649292 0.65 KDM4E (0.50) HTR2CHTR2AGAA
SCHEMBL22477050 0.65 KDM4E (0.34) HTR2CHTR2BHTR2AMAOBMAOA
SCHEMBL4501903 0.64
SCHEMBL24283165 0.64 ACHE (0.43) HTR2CHTR2BHTR2AMAOBMAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3401306-B1 DEZOCINE ANALOGUE SHANDONG DANHONG PHARMACEUTICAL CO LTD (CN) 2020-09-30 EP disclosed
US-10414718-B2 Dezocine analogue SHANDONG DANHONG PHARMACEUTICAL CO., LTD. (CN) 2019-09-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10414718-B2 Dezocine analogue DDO, DDC, DAO TAAR1 1278/4885HTR2C 76/4885HTR2B 487/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.